Supplier Type
- Manufacturer
- Reagent
- Trader
Supplier Region
- Hyderabad(6)
- Mumbai(3)
- Pune(2)
- Gujarat(2)
- Karnataka(1)
- Beijing(1)
- Maharashtra(1)
- Ahmedabad(1)
- Vadodara(1)
- Nagpur(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT95%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.73%
- 99.42%
- 99.29%
- 99%
- 98.60%
- 98.12%
- 98%
- 97-99%
- 97-99 %
- 97.57%
- 97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- >95%
- 95%
- >92%
- 90%
- >90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25MG
- 1g
- 5g
- 25g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 1MT
- 95NLT %
-
Furan, 3-[4-[(2-chlorophenyl)methyl]phenoxy]tetrahydro-, (3S)-
2517968-35-1
-
Empagliflozin Impurity D
-
D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, (1S)-
333359-90-3
-
N-(4,5-Dihydro-1H-iMidazol-2-yl)-6-quinoxalinaMine
91147-43-2
-
ERYTHROMYCIN IMPURITY N
-
L 683519
132172-14-6
-
3'-Demethyl-12-deoxyerythromycin
33442-56-7
-
AzithroMycin IMpurity C
-
1-Hydroxyibuprofen
53949-53-4
Empagliflozin Desbromo Impurity 2517968-35-1
Manufacturer
Note:Purity: NLT 95% | Package: 25 MG 50 MG 100 MG 250 MG EXTRA
4Y
Hyderabad
Product catalog:
1000
Mumbai
Product catalog:
82
Pune
Product catalog:
57
Pune
Product catalog:
172
Hyderabad
Product catalog:
41
Mumbai
Product catalog:
181
1Y
Hyderabad
Product catalog:
44
Reagent
Note:Purity: more than 90% | Package: 1Milligram;
Karnataka
Product catalog:
11
Empagliflozin 864070-44-0
Manufacturer










